Johnson & Johnson (JNJ)

132.48
2.05 1.57
NYSE : Health Technology
Prev Close 130.43
Open 131.07
Day Low/High 130.57 / 132.88
52 Wk Low/High 118.62 / 148.32
Volume 7.52M
Avg Volume 6.28M
Exchange NYSE
Shares Outstanding 2.68B
Market Cap 347.42B
EPS 0.50
P/E Ratio 249.04
Div & Yield 3.60 (2.63%)
JetBlue, Southwest, Johnson & Johnson: 'Mad Money' Lightning Round

JetBlue, Southwest, Johnson & Johnson: 'Mad Money' Lightning Round

Jim Cramer takes a look at JetBlue, Southwest, Johnson & Johnson, Aspen Technology, Stratasys, Laredo Petroleum, Lumber Liquidators, and more.

Worried About the Right Thing?: Cramer's 'Mad Money' Recap (Tuesday 8/14/18)

Worried About the Right Thing?: Cramer's 'Mad Money' Recap (Tuesday 8/14/18)

Jim Cramer says some people are worried about tariffs and Turkey, but he's more concerned about spending patterns at home.

Jim Cramer: Could Turkey Prove to Be One More Buying Opportunity?

Jim Cramer: Could Turkey Prove to Be One More Buying Opportunity?

I always say that you should wait until you get an exogenous reason for stocks to come down and then you should pounce.

Buy Johnson & Johnson, Now Poised to Rally

Buy Johnson & Johnson, Now Poised to Rally

Johnson & Johnson prices finally look ready to move up.

Jim Cramer: 5 Sectors to Buy on This 'Turkish Contagion' Market Drop

Jim Cramer: 5 Sectors to Buy on This 'Turkish Contagion' Market Drop

It is all about perception, and here are strong names to pick up on market weakness.

The 4 Cheapest 'Dividend Kings' to Buy Today

The 4 Cheapest 'Dividend Kings' to Buy Today

These stocks offer not only terrific histories of dividend increases, but are also trading at reasonable valuations.

Your Game Plan For Earnings: Cramer's 'Mad Money' Recap (Friday 8/3/18)

Your Game Plan For Earnings: Cramer's 'Mad Money' Recap (Friday 8/3/18)

Jim Cramer has the game plan for next week, and he also talks about how to buy stocks that are right for you.

The 4 Cheapest 'Dividend Kings' to Buy Today

These stocks offer not only terrific histories of dividend increases, but are also trading for reasonable valuations.

Tech Rotation Hits Market; Bullpen Update

We are looking at today's rotation as an opportunity to pick up a high-quality name at a discount.

13 Lucky Blue Chip Stocks to Buy With the Market Looking Shaky

13 Lucky Blue Chip Stocks to Buy With the Market Looking Shaky

Blue Chip stocks are the way to go right now. Here are several key names worth considering.

Jim Cramer: How to Pick Stocks When the Market Is Flying Blind

Jim Cramer: How to Pick Stocks When the Market Is Flying Blind

This market clearly has no clue what to buy, with strong GDP growth but challenging trade dynamics and the Facebook and Twitter bombs last week.

All New Rules for This Market: Cramer's 'Mad Money' Recap (Friday 7/27/18)

All New Rules for This Market: Cramer's 'Mad Money' Recap (Friday 7/27/18)

Jim Cramer's new rules of the road will help investors stay on course and avoid common mistakes.

3 Great Stocks for Retirees to Own

3 Great Stocks for Retirees to Own

Looking for stocks with a steady stream of income? Check these three names out from TheStreet.

Johnson & Johnson Is a Great Company, But Be Patient

Johnson & Johnson Is a Great Company, But Be Patient

Bulls see a $158 price target, but JNJ needs a rally to $135.28 for a breakout.

Kevin O'Leary's 'Wonderful' World of ETFs: 3 Great Ways to Follow the Shark

Kevin O'Leary's 'Wonderful' World of ETFs: 3 Great Ways to Follow the Shark

These funds from the Shark Tank star's O'Shares series focus on small-cap dividend names, internet giants and large-cap dividend U.S. dividend stocks.

Three Key Takeaways From Healthcare Earnings Season

Three Key Takeaways From Healthcare Earnings Season

Drug pricing remains front and center as healthcare companies start reporting quarterly results.

Rewind: Why Jim Cramer Is Bullish on Johnson & Johnson Shares

Rewind: Why Jim Cramer Is Bullish on Johnson & Johnson Shares

TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer is bullish on Johnson & Johnson shares.

Market Refuses To Go Lower: Cramer's 'Mad Money' Recap (Tuesday 7/17/18)

Market Refuses To Go Lower: Cramer's 'Mad Money' Recap (Tuesday 7/17/18)

Investors have never gone wrong buying Netflix on the dips. Jim Cramer tells you what to make of the 'FANG Musketeers.'

J&J Vows to Fight Verdict Linking Baby Powder to Ovarian Cancer

J&J Vows to Fight Verdict Linking Baby Powder to Ovarian Cancer

One lawyer likens the case to Big Tobacco's fight for decades against lung cancer sufferers who smoked.

Markets Close Higher After Fed Chair Powell's Capitol Hill Testimony

Markets Close Higher After Fed Chair Powell's Capitol Hill Testimony

All three major indices reversed early losses to end higher Tuesday.

Jim Cramer: A Pretty Wild Rally In Three Oppositional Groups

Jim Cramer: A Pretty Wild Rally In Three Oppositional Groups

How can this be? Let's take a look at the camps so we can figure it out.

Jim Cramer on Johnson & Johnson's Pharmaceuticals Sales Growth

Jim Cramer on Johnson & Johnson's Pharmaceuticals Sales Growth

When investors review a drug company, pay close attention to its pharma performance, according to TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer.

Jim Cramer on Netflix, Goldman Sachs, Bank of America and Johnson & Johnson

Jim Cramer on Netflix, Goldman Sachs, Bank of America and Johnson & Johnson

TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer weighs in on Tuesday's trending stocks from the floor of the New York Stock Exchange.

Netflix, Amazon, Jerome Powell, Walmart and Microsoft - 5 Things You Must Know

Netflix, Amazon, Jerome Powell, Walmart and Microsoft - 5 Things You Must Know

U.S. stock futures are lower Tuesday ahead of Federal Reserve Chairman Jerome Powell's first testimony before Congress; Netflix slumps as it misses estimates on subscribers growth; Amazon's Prime Day has a giant hiccup.

Highs (and Lows) of FANG Trading: Market Recon

Highs (and Lows) of FANG Trading: Market Recon

My Netflix short was a big winner yesterday, but I am also long Amazon and Google, which were hit with pretty strong collateral damage.

Bank Leadership Is Covering Up Some Ugly Market Issues

Bank Leadership Is Covering Up Some Ugly Market Issues

This quarter Netflix is not going to be the star of earnings season.

Stocks Drift, Oil Steadies, Dollar Dips as Investors Question Growth Prospects

Stocks Drift, Oil Steadies, Dollar Dips as Investors Question Growth Prospects

Global stocks drifted lower Tuesday, as oil prices remained in correction territory and investors re-set expectations for future U.S. rate hikes amid worrying signals from the bond market, as investors question the underlying strength of the world economy heading into the second half of the year.

TheStreet Quant Rating: B (Buy)